Welcome to the Brain Neuron Research Lab! In our lab, we are passionate about uncovering the mysteries of the intricate network of neurons in the brain. Our main focus is to understand the critical roles of axons, dendrites and synapses, specialized components that are essential for the connections between neurons. We know that when these connections are disrupted, it can significantly impact brain function. Our primary goal is to investigate how cellular and molecular factors contribute to the formation and organization of these essential neuron connections. Additionally, we are curious […]
Isakson Center
June 30, 2026
My research is in the area of Psychopharmacology. My broad interests concern the neurobiological basis of motivation and emotion. More specifically, I am interested in the neurobiological mechanisms responsible for stress resilience and regulation of affective motivation. Much of this work has focused on brain noradrenergic systems and galanin, which is the major peptide coexisting with norepinephrine. Previous research in my laboratory has focused on changes in neurotransmitter systems that occur in rodent models of depression. Other studies have examined the neurobiological basis for the comorbidity of depression and drug […]
June 30, 2026
Dr. Hostetter is the Barry G. Harmon Professor and Head of the Department of Pathology in the College of Veterinary Medicine. He also is the Executive Director of the Tifton and Athens Veterinary Diagnostic Laboratories. In these positions he is responsible for all aspects of the service, teaching and research missions of the department and for the state veterinary diagnostic laboratories in Athens and Tifton Georgia.
June 30, 2026
Shelley Hooks is the vice chancellor for research at the University of Kansas, where she co-leads the research enterprise across all KU campuses. She is also a professor in the Department of Pharmacology & Toxicology. In addition to leading the Office of Research, Hooks advocates for research on and off campus, implements research integrity requirements, and oversees the administration of research grants and contracts. Hooks also shares oversight of activities related to technology commercialization and business and industry outreach. Hooks came to KU in 2024 from the University of Georgia, […]
June 30, 2026
October 1st, 2018, Hart moved to take a position as the Georgia Research Alliance William Henry Terry, Sr. Eminent Scholar in Drug Discovery, and Professor of Biochemistry and Molecular Biology at the Complex Carbohydrate Research Center, University of Georgia. Prior to that appointment, he worked at Johns Hopkins Medical School for 41 years. He has served as the Director of Biological Chemistry at JHU SOM for over 20 years. Hart was elected as a Fellow of ASBMB in 2022 and the President of ASBMB (2018-2020). Hart received the 2019 President’s Innovator Award from the Society for Glycobiology […]
June 30, 2026
Dr. Haltiwanger received his B.S. in Biology (1980) and Ph.D. in Biochemistry (1986) from Duke University. He went on to do postdoctoral work at Johns Hopkins University School of Medicine, and took his first independent position as an Assistant Professor in the Department of Biochemistry and Cell Biology at Stony Brook University (1991). He rose through the ranks to full Professor and served as Chair of that Department for 8 years. He moved to the CCRC in 2015 as the GRA Eminent Scholar in Biomedical Glycosciences. He has served as […]
June 30, 2026
Expertise Autoimmunity | Biomarkers | Cell Marker | Endocrinology | Immunotoxicology | Molecular Mechanisms | Neuroendocrinology | Prenatal Programming | Toxicology Research Interests Toxicology of nanobiomaterials and endocrine disruptors Mechanisms of diabetes and asthma Probiotics, microbiome and immunotoxicology Translational research (www.devertigo.com)
June 30, 2026
Dr. Glenn develops and uses new genomic tools to investigate processes in evolutionary biology and solve problems in environmental health and infectious disease ecology. Research: comparative and environmental genomics, molecular ecology, infectious disease and vectors Teaching: fundamentals of environmental health science, environmental genomics, genome technologies Affiliations: Department of Genetics, Franklin College of Arts & Sciences Institute of Bioinformatics Odum School of Ecology Faculty of Infectious Diseases Biomedical & Health Sciences Institute Savannah River Ecology Lab Interdisciplinary Toxicology Program Center for the Ecology of Infectious Diseases
June 30, 2026
Undergraduate Affairs Committee (Genetics) University Research Animal Resources, Faculty Advisory Committee Developmental Biology Alliance Executive Committee March of Dimes Basil O’Connor Starter Scholar Award Faculty of 1000 member, Pattern Formation Editorial advisory board member: Cilia; Development Current grant support: “Regulation of Hedgehog signaling transcriptional responses by the cell cycle” NIH/NICHD; “Control of TGF-beta signals by Rab23 and Megf8 in mammalian left-right patterning” NIH/NICHD; EDGE: Establishment of genome-editing and transgenic tools in Anolis lizards. (Menke, Eggenschwiler, Lauderdale), NSF Courses Taught at UGA:GENE4310: Genetic Approaches to Developmental Neuroscience; GRSC 7770; BCMB/CBIO/GENE 8112/8113/8212; GENE8880; GENE4950, GENE3200, GENE4230L. Research […]
June 30, 2026
My research is centered on understanding how diet composition modulates behavior, in particular feeding behavior. The vagus nerve is a direct neural pathway that conveys post-ingestive feedback from the gastrointestinal (GI) tract to the brain and proper gut-brain communication is critical for regulation of feeding. Thus, my main interest has been to understand how post-ingestive cues from the GI tract are dysregulated to promote overeating. I have focused my efforts on identifying mechanisms by which diet affects vagal sensory neurons signaling, in particular diet-driven alterations in microbiota composition.
June 30, 2026
Lab association: Clinical and Cognitive Neuroscience Laboratory Franklin Foundation Neuroimaging Training Program Publications and other professional information can be viewed on Dr. Clementz’s vita Curriculum Vitae: BAC CV – 15 August 2016.pdf (356.85 KB)
June 30, 2026
The eukaryotic genome is highly organized. This is critical for efficient and precise access and regulation of individual genes in the enormous and often highly compact genomes. Therefore, the higher order chromatin structure and the epigenetic organization of the genome can directly impact selective gene activation during animal development and physiological responses. Mutations in DNA and protein components that regulate the epigenome have also been implicated in various human diseases. However, despite intense research efforts, mechanisms that facilitate these epigenetic regulations are still poorly understood. A focus of my lab […]
June 30, 2026
Research Interests The Bartlett Lab focuses on applications of analytical chemistry to study biological problems. Currently, we are studying the absorption, distribution, metabolism and excretion (ADME) of pre-clinical and clinical drug substances with the goal of developing novel methods to address significant questions in the biomedical sciences. One area of significant focus is on the development of improved LC-MS methods for the analysis of oligonucleotide therapeutics and biomarkers. We also have an interest in the regulatory sciences including inspection trends and policy evaluation. Research Areas: Methods to determine therapeutic agents, […]
June 30, 2026
Dr. Barany received her bachelor’s degree in neuroscience and mathematics from Hamilton College in Clinton, NY. She received her master’s degree in Psychology and Ph.D. in Dynamical Neuroscience at the University of California, Santa Barbara, and completed postdoctoral fellowships focusing on stroke neurorehabilitation and sensorimotor neuroscience at Emory University and the University of Georgia. At UGA, Dr. Barany directs the Brain and Action Laboratory and co-directs the Neurostimulation Laboratory. She also teaches in the pre-clinical curriculum at the Augusta University/University of Georgia Medical Partnership on the UGA Health Sciences Campus. Dr. Deborah […]
June 30, 2026
Dr. Anantharam is primarily employed at PK Biosciences Corporation and Probiome Therapeutics as the Chief Scientific Officer. After recently being recruited, he is currently the Part-Time Professor of Physiology and Pharmacology at the University of Georgia, Athens. He has a broad background and over 30 years of research experience in molecular neurobiology, neuropharmacology and neurotoxicology. His research focuses on neurodegenerative diseases and neurotoxicology, specifically, mitochondrial dysfunction, oxidative stress, protein aggregation, neuroinflammation and apoptosis in neurotoxicity models of Parkinson’s and prion diseases. During his research career, he has published more than 190 peer reviewed research papers. With […]
June 29, 2026
Research aims to understand how dopamine (DA) neurons die in Parkinson’s disease (PD) and why substantia nigra compacta DA neurons are specifically susceptible in the hope of developing new therapeutic targets for the future. Her laboratory is using a combination of cutting-edge optical, electrochemical, electrophysiological, and genetic approaches to address these questions. Research Focus Understanding how dopamine (DA) neurons die in Parkinson’s disease (PD) and why substantia nigra compacta dopamine neurons are specifically susceptible in hope of developing new therapeutic targets
June 29, 2026
I am a proud graduate of UGA (Ph.D. Genetics). After spending over 20 years on the faculty at Iowa State University, have welcomed the chance to return to UGA as a Professor in ICNDR and Department of Infectious Diseases. Research Focus Our lab engineers life biotherapeutic products in the form of beneficial microorganisms as novel treatment of neurodegenerative diseases. We also investigate the role of the gut microbiome in host health and disease processes. Development of live biotherapeutic products to treat disease Investigating the role of the microbiome in neurological […]
June 29, 2026
Research focuses on the functional organization of the olfactory and related systems in health and disease including Alzheimer’s disease (AD) at the cellular and circuit levels with multidisciplinary and cutting-edge technologies including optogenetics, chemogenetics, in vivo and in vitro electro physiology, behavioral approaches, and neuroanatomy with advanced cellular imaging. Research Focus Elucidating how olfactory and limbic systems are effected in diseases such as Alzheimer’s disease, Parkinson’s disease, and brain injuries due to trauma or neurotoxicity Using optogenetics, chemogenetics, in vivo and in vitro electro-physiology, behavioral approaches, and neuroanatomy with advanced […]
June 29, 2026
My early work addressed the role of oxidative stress signaling events, UPS dysfunction and apoptotic mechanisms in dopaminergic neurotoxicant-induced cellular injury. Recently, our lab has focused on understanding the molecular mechanisms by which PKCδ regulates the apoptotic cell signaling cascade following exposure to dopaminergic neurotoxicants. We discovered that mitochondria-mediated oxidative stress signaling events in conjunction with the caspase-3-mediated cell death signaling cascade contribute to the demise of dopaminergic neuronal cells via the activation of PKCδ. Moreover, we demonstrated the functional cross-talk between histone hyperacetylation and PKCδ upregulation in dopaminergic neuronal […]
June 29, 2026
Research conducted by Dr. Richardson focuses on the role of environmental exposures and their interactions with genetic susceptibility as contributors to neurological disease using translational approaches. He has recruited and led multidisciplinary teams of researchers to explore gene-environment interactions relevant to Parkinson’s disease, Alzheimer’s disease, and Attention Deficit Hyperactivity Disorder, ADHD. Through the conduct of basic and epidemiological studies, he has contributed several significant findings that have broad implications for human health, individual susceptibility, and risk assessment as it relates to neurodegenerative disease and neurodevelopmental disorders. These efforts have been […]
June 29, 2026
Dr. Kanthasamy’s research program has been at the forefront in unraveling the cell signaling mechanisms underlying key pathophysiological processes of PD, including mitochondrial dysfunction, oxidative stress, dopaminergic therapy, aSyn protein aggregation, gut microbiota dysbiosis, exosome trafficking, neuroinflammation, and apoptosis. Furthermore he and his team recently adopted a highly sensitive RT-QuIC assay to successfully detect ultralow levels of pathologic αSyn aggregates from serum, plasma, CSF and submandibular and skin samples from PD and related Parkinsonian disorders. Dr. Kanthasamy’s lab translational research efforts also involve testing the efficacy of several small-molecule, peptide, […]